HPC6
MCID: PRS136
MIFTS: 33

Prostate Cancer, Hereditary, 6 (HPC6)

Categories: Cancer diseases, Genetic diseases, Rare diseases, Reproductive diseases

Aliases & Classifications for Prostate Cancer, Hereditary, 6

MalaCards integrated aliases for Prostate Cancer, Hereditary, 6:

Name: Prostate Cancer, Hereditary, 6 57 13 70
Prostate Cancer, Susceptibility to 57
Prostate Cancer 57
Hpc6 57

Classifications:



External Ids:

OMIM® 57 609558
MedGen 41 C1836005
UMLS 70 C1836005

Summaries for Prostate Cancer, Hereditary, 6

MalaCards based summary : Prostate Cancer, Hereditary, 6, also known as prostate cancer, susceptibility to, is related to prostate cancer and prostate cancer, hereditary, 1. An important gene associated with Prostate Cancer, Hereditary, 6 is HPC6 (Prostate Cancer, Susceptibility To). The drugs Ofloxacin and Levofloxacin have been mentioned in the context of this disorder. Affiliated tissues include prostate, bone and lymph node.

More information from OMIM: 609558

Related Diseases for Prostate Cancer, Hereditary, 6

Diseases in the Prostate Cancer family:

Prostate Cancer, Hereditary, 1 Prostate Cancer, Hereditary, 8
Prostate Cancer, Hereditary, 3 Prostate Cancer, Hereditary, 4
Prostate Cancer, Hereditary, 5 Prostate Cancer, Hereditary, 6
Prostate Cancer, Hereditary, 7 Prostate Cancer, Hereditary, 9
Prostate Cancer, Hereditary, 10 Prostate Cancer, Hereditary, 12
Prostate Cancer, Hereditary, 13 Prostate Cancer, Hereditary, 11
Prostate Cancer, Hereditary, 14 Prostate Cancer, Hereditary, 15
Prostate Cancer, Hereditary, 2 Prostate Carcinoma in Situ

Diseases related to Prostate Cancer, Hereditary, 6 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1213, show less)
# Related Disease Score Top Affiliating Genes
1 prostate cancer 12.3
2 prostate cancer, hereditary, 1 11.7
3 prostate cancer, hereditary, 2 11.7
4 prostate cancer, hereditary, 13 11.6
5 prostate cancer, hereditary, 12 11.6
6 prostate cancer, hereditary, 4 11.6
7 prostate cancer, hereditary, 11 11.6
8 pachyonychia congenita 3 11.5
9 prostate cancer, hereditary, 8 11.5
10 prostate cancer, hereditary, 3 11.5
11 prostate cancer, hereditary, 9 11.4
12 prostate cancer, hereditary, x-linked 1 11.4
13 prostate cancer/brain cancer susceptibility 11.4
14 prostatic hypertrophy 11.4
15 prostate cancer, hereditary, 7 11.4
16 prostatic hyperplasia, benign 11.4
17 prostatic adenoma 11.4
18 prostate cancer, hereditary, 10 11.3
19 prostate cancer, hereditary, 15 11.3
20 prostate cancer, hereditary, 14 11.3
21 prostate disease 11.3
22 prostate cancer, hereditary, x-linked 2 11.3
23 prostate cancer, hereditary, 5 11.3
24 suppression of tumorigenicity 12 11.2
25 impotence 11.2
26 diethylstilbestrol syndrome 11.1
27 radiation proctitis 11.1
28 hereditary breast ovarian cancer syndrome 11.1
29 prostate cancer aggressiveness quantitative trait locus on chromosome 19 11.1
30 breast-ovarian cancer, familial 2 11.1
31 alopecia, androgenetic, 1 11.1
32 breast-ovarian cancer, familial 1 11.0
33 prostate sarcoma 11.0
34 gastric cancer, hereditary diffuse 11.0
35 severe combined immunodeficiency 11.0
36 prostatitis 11.0
37 sexual disorder 10.9
38 neutropenia 10.9
39 adenocarcinoma 10.9
40 hypoxia 10.9
41 bladder cancer 10.9
42 bone disease 10.9
43 proctitis 10.8
44 body mass index quantitative trait locus 1 10.8
45 bone resorption disease 10.8
46 insulin-like growth factor i 10.8
47 hypogonadism 10.8
48 47,xyy 10.8
49 pik3ca-related overgrowth syndrome 10.8
50 bone mineral density quantitative trait locus 8 10.8
51 bone mineral density quantitative trait locus 15 10.8
52 osteoporosis 10.8
53 skin carcinoma 10.8
54 retinoblastoma 10.8
55 infant gynecomastia 10.8
56 gynecomastia 10.8
57 urethral stricture 10.7
58 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.7
59 48,xyyy 10.7
60 cystitis 10.7
61 thrombocytopenia 10.7
62 cytokine deficiency 10.7
63 b-cell lymphoma 10.7
64 urinary tract infection 10.7
65 tumor predisposition syndrome 10.6
66 cutaneous telangiectasia and cancer syndrome, familial 10.6
67 constipation 10.6
68 inherited cancer-predisposing syndrome 10.6
69 myopathy, myosin storage, autosomal recessive 10.6
70 body mass index quantitative trait locus 11 10.6
71 depression 10.6
72 body mass index quantitative trait locus 9 10.6
73 body mass index quantitative trait locus 8 10.6
74 body mass index quantitative trait locus 4 10.6
75 body mass index quantitative trait locus 10 10.6
76 anxiety 10.6
77 body mass index quantitative trait locus 7 10.6
78 body mass index quantitative trait locus 12 10.6
79 body mass index quantitative trait locus 14 10.6
80 body mass index quantitative trait locus 18 10.6
81 body mass index quantitative trait locus 19 10.6
82 exanthem 10.6
83 alopecia 10.6
84 withdrawal disorder 10.6
85 rectum cancer 10.6
86 herpes simplex 10.6
87 osteonecrosis 10.6
88 diarrhea 10.6
89 lipid metabolism disorder 10.6
90 ataxia-telangiectasia 10.6
91 renal cell carcinoma, nonpapillary 10.6
92 small cell carcinoma 10.6
93 ataxia and polyneuropathy, adult-onset 10.6
94 kidney cancer 10.6
95 hypokalemia 10.6
96 rapidly involuting congenital hemangioma 10.6
97 telangiectasis 10.6
98 vaccinia 10.6
99 hyperglycemia 10.6
100 rickets 10.6
101 osteonecrosis of the jaw 10.6
102 helix syndrome 10.6
103 disseminated intravascular coagulation 10.6
104 lymph node carcinoma 10.5
105 melanoma 10.5
106 peripheral nervous system disease 10.5
107 neuroendocrine carcinoma 10.5
108 neuropathy 10.5
109 triiodothyronine receptor auxiliary protein 10.5
110 ovarian cancer 10.5
111 human immunodeficiency virus type 1 10.5
112 lynch syndrome 10.5
113 diabetes mellitus 10.5
114 hypercholesterolemia, familial, 1 10.5
115 urinary tract obstruction 10.5
116 lymphopenia 10.5
117 breast cancer 10.5
118 hydronephrosis 10.5
119 lymphocele 10.5
120 stomatitis 10.5
121 combined immunodeficiency 10.5
122 pulmonary embolism 10.5
123 myeloma, multiple 10.5
124 transitional cell carcinoma 10.5
125 acute cystitis 10.5
126 neuroendocrine tumor 10.5
127 hyperinsulinism 10.5
128 osteogenic sarcoma 10.4
129 proteasome-associated autoinflammatory syndrome 1 10.4
130 thrombophilia due to thrombin defect 10.4
131 type 2 diabetes mellitus 10.4
132 adenoma 10.4
133 factor vii deficiency 10.4
134 hypophosphatemia 10.4
135 mucositis 10.4
136 back pain 10.4
137 familial adenomatous polyposis 10.4
138 b-lymphoblastic leukemia/lymphoma 10.4
139 inflammatory bowel disease 10.4
140 leukemia 10.4
141 in situ carcinoma 10.4
142 lung cancer susceptibility 3 10.4
143 lymphoma 10.4
144 lymph node disease 10.4
145 androgenic alopecia 10.4
146 low compliance bladder 10.4
147 thyroid carcinoma 10.4
148 dementia 10.4
149 vascular disease 10.4
150 sensory peripheral neuropathy 10.4
151 glioblastoma 10.4
152 congestive heart failure 10.4
153 hemorrhoid 10.4
154 meningioma, familial 10.4
155 coronary heart disease 1 10.4
156 paraplegia 10.4
157 radiation cystitis 10.4
158 chronic fatigue syndrome 10.4
159 pituitary tumors 10.4
160 hypertriglyceridemia, familial 10.4
161 anal fistula 10.4
162 intracranial meningioma 10.4
163 pertussis 10.4
164 secretory meningioma 10.4
165 lymphoplasmacyte-rich meningioma 10.4
166 ureteral obstruction 10.4
167 xeroderma pigmentosum, variant type 10.4
168 aging 10.4
169 osteomyelitis 10.4
170 chlamydia 10.4
171 endometrial cancer 10.3
172 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.3
173 bone cancer 10.3
174 neuroblastoma 10.3
175 colorectal cancer 10.3
176 myocardial infarction 10.3
177 sarcoma 10.3
178 tic disorder 10.3
179 spindle cell sarcoma 10.3
180 lung cancer 10.3
181 polykaryocytosis inducer 10.3
182 inguinal hernia 10.3
183 osteomalacia 10.3
184 heart disease 10.3
185 severe acute respiratory syndrome 10.3
186 testicular cancer 10.3
187 acne 10.3
188 chromosomal triplication 10.3
189 female breast cancer 10.3
190 hereditary lymphedema i 10.3
191 pancytopenia 10.3
192 hypothyroidism 10.3
193 mental depression 10.3
194 acute kidney failure 10.3
195 pituitary adenoma 10.3
196 bladder urothelial carcinoma 10.3
197 end stage renal disease 10.3
198 ileus 10.3
199 laurence-moon syndrome 10.3
200 alzheimer disease 10.3
201 hyperparathyroidism 10.3
202 ulcerative colitis 10.3
203 granulocytopenia 10.3
204 pancreatic cancer 10.3
205 major depressive disorder 10.3
206 myelodysplastic syndrome 10.3
207 deficiency anemia 10.3
208 covid-19 10.3
209 urethritis 10.3
210 squamous cell papilloma 10.3
211 papilloma 10.3
212 mammary paget's disease 10.3
213 syphilis 10.3
214 infertility 10.3
215 kidney disease 10.3
216 crohn's disease 10.3
217 cerebrofacial arteriovenous metameric syndrome 10.3
218 polyploidy 10.3
219 immune deficiency disease 10.3
220 lymphoma, hodgkin, classic 10.3
221 multicentric carpotarsal osteolysis syndrome 10.3
222 lynch syndrome i 10.3
223 leukemia, acute myeloid 10.3
224 hemophagocytic lymphohistiocytosis, familial, 2 10.3
225 hemorrhagic cystitis 10.3
226 allergic disease 10.3
227 plasmacytoma 10.3
228 muscular atrophy 10.3
229 myeloid leukemia 10.3
230 hereditary nonpolyposis colon cancer 10.3
231 taqi polymorphism 10.2
232 wilms tumor 1 10.2
233 esophageal cancer 10.2
234 alcohol dependence 10.2
235 paragangliomas 3 10.2
236 ectodermal dysplasia-syndactyly syndrome 2 10.2
237 gastric cancer 10.2
238 hyperprolactinemia 10.2
239 diphtheria 10.2
240 purpura 10.2
241 bone inflammation disease 10.2
242 cerebrovascular disease 10.2
243 spinal cord injury 10.2
244 arts syndrome 10.2
245 fanconi anemia, complementation group a 10.2
246 leukemia, chronic lymphocytic 10.2
247 cardiac conduction defect 10.2
248 retinitis pigmentosa 11 10.2
249 peripheral vascular disease 10.2
250 ptosis 10.2
251 pituitary apoplexy 10.2
252 cholestasis 10.2
253 alcohol use disorder 10.2
254 basal cell carcinoma 10.2
255 benign mesothelioma 10.2
256 mucinous adenocarcinoma 10.2
257 fibrosarcoma 10.2
258 appendix adenocarcinoma 10.2
259 liver disease 10.2
260 priapism 10.2
261 soft tissue sarcoma 10.2
262 paraneoplastic syndromes 10.2
263 androgen insensitivity syndrome 10.2
264 li-fraumeni syndrome 10.2
265 autoimmune disease 10.2
266 stroke, ischemic 10.2
267 lymphoma, non-hodgkin, familial 10.2
268 leukemia, chronic myeloid 10.2
269 colorectal adenoma 10.2
270 bacterial infectious disease 10.2
271 respiratory failure 10.2
272 brain cancer 10.2
273 disease of mental health 10.2
274 orchitis 10.2
275 arthritis 10.2
276 congenital extrahepatic portosystemic shunt 10.2
277 acute sensory ataxic neuropathy 10.2
278 46,xy disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect 10.2
279 xeroderma pigmentosum, complementation group c 10.2
280 xeroderma pigmentosum, complementation group d 10.2
281 wiskott-aldrich syndrome 10.2
282 spondylometaphyseal dysplasia, sedaghatian type 10.2
283 kaposi sarcoma 10.2
284 hepatocellular carcinoma 10.2
285 atherosclerosis susceptibility 10.2
286 cervical cancer 10.2
287 acute promyelocytic leukemia 10.2
288 human herpesvirus 8 10.2
289 metabolic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration 10.2
290 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.2
291 secondary progressive multiple sclerosis 10.2
292 pain agnosia 10.2
293 thrombotic thrombocytopenic purpura 10.2
294 male infertility 10.2
295 secondary hyperparathyroidism 10.2
296 hemolytic-uremic syndrome 10.2
297 squamous cell carcinoma 10.2
298 leiomyosarcoma 10.2
299 post-traumatic stress disorder 10.2
300 colon adenocarcinoma 10.2
301 liposarcoma 10.2
302 breast adenocarcinoma 10.2
303 rhinitis 10.2
304 exophthalmos 10.2
305 cap myopathy 10.2
306 rare tumor 10.2
307 overgrowth syndrome 10.2
308 small cell cancer of the lung 10.1
309 rheumatoid arthritis 10.1
310 asthma 10.1
311 yemenite deaf-blind hypopigmentation syndrome 10.1
312 pulmonary disease, chronic obstructive 10.1
313 ovarian cancer 1 10.1
314 fanconi anemia, complementation group j 10.1
315 tatton-brown-rahman syndrome 10.1
316 disease by infectious agent 10.1
317 gout 10.1
318 toxic shock syndrome 10.1
319 optic nerve disease 10.1
320 newcastle disease 10.1
321 gastric adenocarcinoma 10.1
322 cranial nerve palsy 10.1
323 myopathy 10.1
324 carcinosarcoma 10.1
325 cribriform carcinoma 10.1
326 hemolytic anemia 10.1
327 chronic kidney disease 10.1
328 fatty liver disease 10.1
329 fasciitis 10.1
330 oncogenic osteomalacia 10.1
331 headache 10.1
332 paresthesia 10.1
333 thrombotic microangiopathy 10.1
334 precursor t-cell acute lymphoblastic leukemia 10.1
335 thymoma, familial 10.1
336 hemophilia a 10.1
337 kearns-sayre syndrome 10.1
338 nijmegen breakage syndrome 10.1
339 bloom syndrome 10.1
340 tuberous sclerosis 1 10.1
341 trichorhinophalangeal syndrome, type i 10.1
342 factor viii deficiency 10.1
343 bone mineral density quantitative trait locus 3 10.1
344 nasopharyngeal carcinoma 10.1
345 mycobacterium tuberculosis 1 10.1
346 proteinuria, chronic benign 10.1
347 peyronie's disease 10.1
348 diffuse large b-cell lymphoma 10.1
349 large cell neuroendocrine carcinoma 10.1
350 sclerosteosis 10.1
351 glucose intolerance 10.1
352 tetanus 10.1
353 adult respiratory distress syndrome 10.1
354 tuberous sclerosis 10.1
355 bladder neck obstruction 10.1
356 pyuria 10.1
357 transient cerebral ischemia 10.1
358 bilirubin metabolic disorder 10.1
359 neurilemmoma 10.1
360 ischemia 10.1
361 thymoma 10.1
362 teratoma 10.1
363 skin disease 10.1
364 paget's disease of bone 10.1
365 acute stress disorder 10.1
366 sporadic breast cancer 10.1
367 appendicitis 10.1
368 lung disease 10.1
369 hemophilia 10.1
370 acquired hemophilia 10.1
371 glioma 10.1
372 oral cancer 10.1
373 radiation induced cancer 10.1
374 anoxia 10.1
375 chronic pain 10.1
376 syncope 10.1
377 tremor 10.1
378 glial tumor 10.1
379 autosomal recessive epidermolytic ichthyosis 10.1
380 spinal and bulbar muscular atrophy, x-linked 1 10.0
381 lipoid congenital adrenal hyperplasia 10.0
382 suppressor of tumorigenicity 3 10.0
383 thyroid cancer, nonmedullary, 1 10.0
384 temporal arteritis 10.0
385 hair whorl 10.0
386 cardiac arrhythmia 10.0
387 aortic aneurysm, familial abdominal, 1 10.0
388 epithelial basolateral chloride conductance regulator, rabbit, homolog of 10.0
389 gastrointestinal stromal tumor 10.0
390 resting heart rate, variation in 10.0
391 fanconi anemia, complementation group i 10.0
392 aplastic anemia 10.0
393 thrombocytopenia 4 10.0
394 major affective disorder 8 10.0
395 major affective disorder 9 10.0
396 leukemia, acute lymphoblastic 10.0
397 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 10.0
398 cholangiocarcinoma 10.0
399 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
400 angina pectoris 10.0
401 follicular lymphoma 10.0
402 generalized epilepsy with febrile seizures plus 10.0
403 lymphoproliferative syndrome 10.0
404 thrombosis 10.0
405 fibrous dysplasia 10.0
406 urolithiasis 10.0
407 mild cognitive impairment 10.0
408 dermatomyositis 10.0
409 nasopharyngitis 10.0
410 hydrocephalus 10.0
411 pyelonephritis 10.0
412 penile cancer 10.0
413 conn's syndrome 10.0
414 bronchus cancer 10.0
415 obstructive jaundice 10.0
416 premature ejaculation 10.0
417 facial paralysis 10.0
418 interstitial cystitis 10.0
419 bacteriuria 10.0
420 cholera 10.0
421 hyperuricemia 10.0
422 acromegaly 10.0
423 pulmonary tuberculosis 10.0
424 prostatic acinar adenocarcinoma 10.0
425 interstitial lung disease 10.0
426 multiple endocrine neoplasia 10.0
427 teratocarcinoma 10.0
428 embryonal carcinoma 10.0
429 bipolar disorder 10.0
430 cellulitis 10.0
431 signet ring cell adenocarcinoma 10.0
432 aortic aneurysm 10.0
433 lung squamous cell carcinoma 10.0
434 gastritis 10.0
435 seminoma 10.0
436 clear cell renal cell carcinoma 10.0
437 intrahepatic cholangiocarcinoma 10.0
438 pneumonia 10.0
439 nephrolithiasis 10.0
440 cowden syndrome 10.0
441 bilateral breast cancer 10.0
442 herpes zoster 10.0
443 subacute delirium 10.0
444 vasculitis 10.0
445 skin melanoma 10.0
446 pemphigus 10.0
447 epididymo-orchitis 10.0
448 acquired hemophilia a 10.0
449 tetraploidy 10.0
450 dysphagia 10.0
451 malignant tumor of penis 10.0
452 avascular necrosis 10.0
453 acute liver failure 10.0
454 squamous cell carcinoma, head and neck 10.0
455 werner syndrome 10.0
456 gonadoblastoma 10.0
457 scott syndrome 10.0
458 hypogonadism, male 10.0
459 hemochromatosis, type 1 10.0
460 cryptorchidism, unilateral or bilateral 10.0
461 adrenocortical carcinoma, hereditary 10.0
462 schistosoma mansoni infection, susceptibility/ 10.0
463 sarcoidosis 1 10.0
464 pheochromocytoma 10.0
465 pernicious anemia 10.0
466 glioma susceptibility 1 10.0
467 exostoses, multiple, type i 10.0
468 arteries, anomalies of 10.0
469 spondyloarthropathy 1 10.0
470 gallbladder disease 1 10.0
471 patent ductus venosus 10.0
472 paragangliomas 2 10.0
473 li-fraumeni syndrome 2 10.0
474 fanconi anemia, complementation group l 10.0
475 glucocorticoid deficiency 4 with or without mineralocorticoid deficiency 10.0
476 estrogen resistance 10.0
477 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.0
478 lipoprotein quantitative trait locus 10.0
479 adrenal cortical carcinoma 10.0
480 autosomal recessive disease 10.0
481 adrenal gland pheochromocytoma 10.0
482 infective endocarditis 10.0
483 ductal carcinoma in situ 10.0
484 estrogen-receptor negative breast cancer 10.0
485 colitis 10.0
486 adenoid cystic carcinoma 10.0
487 middle east respiratory syndrome 10.0
488 aortic dissection 10.0
489 limbic encephalitis 10.0
490 trypanosomiasis 10.0
491 mumps 10.0
492 endocarditis 10.0
493 gastric ulcer 10.0
494 microcephaly 10.0
495 arteriovenous malformation 10.0
496 hemopericardium 10.0
497 cauda equina syndrome 10.0
498 polycystic ovary syndrome 10.0
499 pericardial effusion 10.0
500 inflammatory spondylopathy 10.0
501 acute leukemia 10.0
502 uveitis 10.0
503 nodular prostate 10.0
504 polyneuropathy 10.0
505 schistosomiasis 10.0
506 azoospermia 10.0
507 generalized anxiety disorder 10.0
508 urticaria 10.0
509 lymphadenitis 10.0
510 duodenal ulcer 10.0
511 rectum adenocarcinoma 10.0
512 hyperostosis 10.0
513 arteriosclerosis 10.0
514 iron metabolism disease 10.0
515 myelophthisic anemia 10.0
516 leydig cell tumor 10.0
517 rectosigmoid cancer 10.0
518 endometriosis 10.0
519 glomerulonephritis 10.0
520 malignant astrocytoma 10.0
521 papillary carcinoma 10.0
522 mood disorder 10.0
523 inappropriate adh syndrome 10.0
524 pancreatic ductal adenocarcinoma 10.0
525 lactic acidosis 10.0
526 pulmonary fibrosis 10.0
527 adrenal cortical adenocarcinoma 10.0
528 pancreatic adenocarcinoma 10.0
529 pustulosis of palm and sole 10.0
530 adenosquamous carcinoma 10.0
531 liver cirrhosis 10.0
532 bronchitis 10.0
533 thyroid hyalinizing trabecular adenoma 10.0
534 spondylitis 10.0
535 active peptic ulcer disease 10.0
536 peptic ulcer disease 10.0
537 cataract 10.0
538 osteoarthritis 10.0
539 polycythemia 10.0
540 night blindness 10.0
541 measles 10.0
542 neurofibromatosis 10.0
543 lupus erythematosus 10.0
544 psoriasis 10.0
545 amyloidosis 10.0
546 hypopituitarism 10.0
547 intracranial hypertension 10.0
548 venezuelan equine encephalitis 10.0
549 encephalitis 10.0
550 necrotizing fasciitis 10.0
551 hydrocele 10.0
552 hypoglycemia 10.0
553 carcinoid syndrome 10.0
554 dentinogenesis imperfecta type 2 10.0
555 malakoplakia 10.0
556 primary bone cancer 10.0
557 pseudobulbar affect 10.0
558 aneurysm 10.0
559 encephalopathy 10.0
560 b-cell non-hodgkin lymphoma 10.0
561 benign idiopathic neonatal seizures 10.0
562 argyria 10.0
563 functioning gonadotropic adenoma 10.0
564 sjogren syndrome 9.9
565 46,xy sex reversal 2 9.9
566 sarcoma, synovial 9.9
567 tubulin, beta 9.9
568 polycythemia vera 9.9
569 pituitary hormone deficiency, combined, 2 9.9
570 myasthenia gravis 9.9
571 intracranial hypertension, idiopathic 9.9
572 hutterite cerebroosteonephrodysplasia syndrome 9.9
573 fanconi anemia, complementation group d2 9.9
574 enterocolitis 9.9
575 cystic fibrosis 9.9
576 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.9
577 zinc finger protein 1 9.9
578 thrombocytopenia 2 9.9
579 neural tube defects 9.9
580 schizophrenia 9.9
581 retinal detachment 9.9
582 dowling-degos disease 1 9.9
583 exfoliation syndrome 9.9
584 peyronie disease 9.9
585 nephrolithiasis, calcium oxalate 9.9
586 myositis 9.9
587 antigen defined by monoclonal antibody aj9 9.9
588 medulloblastoma 9.9
589 systemic lupus erythematosus 9.9
590 ige responsiveness, atopic 9.9
591 fibrosis of extraocular muscles, congenital, 1 9.9
592 multiple endocrine neoplasia, type i 9.9
593 amyotrophic lateral sclerosis 1 9.9
594 neurofibromatosis, type ii 9.9
595 macular degeneration, age-related, 1 9.9
596 allergic rhinitis 9.9
597 hamamy syndrome 9.9
598 colorectal cancer 2 9.9
599 ewing sarcoma 9.9
600 microvascular complications of diabetes 5 9.9
601 premature ovarian failure 7 9.9
602 fatty liver disease, nonalcoholic 1 9.9
603 fanconi anemia, complementation group o 9.9
604 muscle hypertrophy 9.9
605 graft-versus-host disease 9.9
606 membranous nephropathy 9.9
607 steel syndrome 9.9
608 smith-mccort dysplasia 2 9.9
609 shaheen syndrome 9.9
610 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.9
611 glucocorticoid resistance, generalized 9.9
612 diarrhea 9 9.9
613 ifap syndrome 2 9.9
614 thrombocytopenia 7 9.9
615 angiosarcoma 9.9
616 acute diarrhea 9.9
617 aspiration pneumonia 9.9
618 restless legs syndrome 9.9
619 sleep apnea 9.9
620 colorectal adenocarcinoma 9.9
621 tongue squamous cell carcinoma 9.9
622 interleukin-7 receptor alpha deficiency 9.9
623 estrogen-receptor positive breast cancer 9.9
624 cardiac arrest 9.9
625 pollen allergy 9.9
626 non-alcoholic fatty liver disease 9.9
627 dedifferentiated liposarcoma 9.9
628 polymyositis 9.9
629 complete androgen insensitivity syndrome 9.9
630 pemphigoid 9.9
631 hypogonadotropic hypogonadism 9.9
632 sleeping sickness 9.9
633 anthracosis 9.9
634 pre-eclampsia 9.9
635 interstitial nephritis 9.9
636 premature menopause 9.9
637 hemiplegia 9.9
638 brucellosis 9.9
639 anogenital venereal wart 9.9
640 primary hyperparathyroidism 9.9
641 onchocerciasis 9.9
642 nephrotic syndrome 9.9
643 osteopoikilosis 9.9
644 hemosiderosis 9.9
645 pica disease 9.9
646 neurogenic bladder 9.9
647 common variable immunodeficiency 9.9
648 dysentery 9.9
649 hepatitis a 9.9
650 leiomyoma 9.9
651 pneumatosis cystoides intestinalis 9.9
652 porphyria 9.9
653 pure red-cell aplasia 9.9
654 eclampsia 9.9
655 multiple cranial nerve palsy 9.9
656 anus cancer 9.9
657 obstructive hydrocephalus 9.9
658 oligospermia 9.9
659 sclerosing cholangitis 9.9
660 papilledema 9.9
661 thrombocytopenia due to platelet alloimmunization 9.9
662 keratosis 9.9
663 pneumothorax 9.9
664 cheilitis 9.9
665 malignant fibrous histiocytoma 9.9
666 trichomoniasis 9.9
667 enthesopathy 9.9
668 hemorrhagic disease 9.9
669 lateral sclerosis 9.9
670 motor neuron disease 9.9
671 gastroenteritis 9.9
672 thrombophilia 9.9
673 dermatitis 9.9
674 acute pancreatitis 9.9
675 substance abuse 9.9
676 high grade glioma 9.9
677 lipomatosis 9.9
678 rhabdomyosarcoma 9.9
679 choriocarcinoma 9.9
680 plexopathy 9.9
681 pseudohermaphroditism 9.9
682 seminal vesicle tumor 9.9
683 adrenal carcinoma 9.9
684 pleomorphic adenoma 9.9
685 brain edema 9.9
686 pancreatitis 9.9
687 adjustment disorder 9.9
688 pituitary gland disease 9.9
689 pulmonary coin lesion 9.9
690 breast lymphoma 9.9
691 compartment syndrome 9.9
692 urethra cancer 9.9
693 diverticulitis 9.9
694 periodontitis 9.9
695 peritonitis 9.9
696 paralytic ileus 9.9
697 bullous pemphigoid 9.9
698 chickenpox 9.9
699 bacterial pneumonia 9.9
700 viral infectious disease 9.9
701 iridocyclitis 9.9
702 acute myocardial infarction 9.9
703 cholangitis 9.9
704 meningitis 9.9
705 diabetic neuropathy 9.9
706 polyarteritis nodosa 9.9
707 ankrd26-related thrombocytopenia 9.9
708 carcinoma showing thymus-like differentiation 9.9
709 cerebellar degeneration 9.9
710 chromosome 16q deletion 9.9
711 chromosome 8p deletion 9.9
712 fournier gangrene 9.9
713 germ cells tumors 9.9
714 microscopic polyangiitis 9.9
715 precocious puberty 9.9
716 retroperitoneal fibrosis 9.9
717 splenomegaly 9.9
718 testicular seminoma 9.9
719 urethral cancer 9.9
720 foot drop 9.9
721 myoclonus 9.9
722 seizure disorder 9.9
723 paraneoplastic limbic encephalitis 9.9
724 inflammatory myopathy with abundant macrophages 9.9
725 rare hereditary hemochromatosis 9.9
726 chronic enteropathy associated with slco2a1 gene 9.9
727 cancer-associated retinopathy 9.9
728 pseudovaginal perineoscrotal hypospadias 9.7
729 rhabdomyosarcoma, embryonal, 1 9.7
730 sarcosinemia 9.7
731 short stature-obesity syndrome 9.7
732 testicular germ cell tumor 9.7
733 fragile x syndrome 9.7
734 hypogonadotropic hypogonadism 1 with or without anosmia 9.7
735 myoclonic epilepsy associated with ragged-red fibers 9.7
736 hyper-igd syndrome 9.7
737 3-methylglutaconic aciduria, type iii 9.7
738 ocular motor apraxia 9.7
739 leprosy 3 9.7
740 mckusick-kaufman syndrome 9.7
741 goodpasture syndrome 9.7
742 farber lipogranulomatosis 9.7
743 fanconi anemia, complementation group c 9.7
744 schopf-schulz-passarge syndrome 9.7
745 dyssegmental dysplasia, rolland-desbuquois type 9.7
746 apparent mineralocorticoid excess 9.7
747 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.7
748 coloboma, ocular, autosomal recessive 9.7
749 chondrosarcoma 9.7
750 celiac disease 1 9.7
751 ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia 9.7
752 ascites, chylous 9.7
753 anemia, autoimmune hemolytic 9.7
754 tangier disease 9.7
755 amelogenesis imperfecta, hypomaturation type, iia1 9.7
756 acrocallosal syndrome 9.7
757 wolf-hirschhorn syndrome 9.7
758 varicose veins 9.7
759 renal hypodysplasia/aplasia 1 9.7
760 ureterocele 9.7
761 down syndrome 9.7
762 tobacco addiction 9.7
763 digeorge syndrome 9.7
764 thrombophilia due to activated protein c resistance 9.7
765 tetralogy of fallot 9.7
766 testicular torsion 9.7
767 supravalvular aortic stenosis 9.7
768 strabismus 9.7
769 scleroderma, familial progressive 9.7
770 pulmonary fibrosis, idiopathic 9.7
771 hutchinson-gilford progeria syndrome 9.7
772 porphyria cutanea tarda 9.7
773 porphyria, acute intermittent 9.7
774 peutz-jeghers syndrome 9.7
775 mccune-albright syndrome 9.7
776 parkinson disease, late-onset 9.7
777 paget disease, extramammary 9.7
778 spinocerebellar ataxia 1 9.7
779 noonan syndrome 1 9.7
780 night blindness, congenital stationary, autosomal dominant 2 9.7
781 cowden syndrome 1 9.7
782 nondisjunction 9.7
783 mirror movements 1 9.7
784 mesothelioma, malignant 9.7
785 melanoma, uveal 9.7
786 melanoma, cutaneous malignant 2 9.7
787 melanoma, cutaneous malignant 1 9.7
788 thyroid carcinoma, familial medullary 9.7
789 lipomatosis, multiple 9.7
790 intussusception 9.7
791 immunoglobulin switch sequences 9.7
792 hypoparathyroidism, familial isolated, 1 9.7
793 hyperparathyroidism 2 with jaw tumors 9.7
794 holt-oram syndrome 9.7
795 exostoses, multiple, type ii 9.7
796 beckwith-wiedemann syndrome 9.7
797 diabetes insipidus, nephrogenic, autosomal 9.7
798 cryoglobulinemia, familial mixed 9.7
799 crouzon syndrome 9.7
800 epithelial recurrent erosion dystrophy 9.7
801 cerebral cavernous malformations 9.7
802 carcinoid tumors, intestinal 9.7
803 progressive familial heart block, type ia 9.7
804 gastroesophageal reflux 9.7
805 antipyrine metabolism 9.7
806 anal canal carcinoma 9.7
807 saethre-chotzen syndrome 9.7
808 acanthosis nigricans 9.7
809 abducens palsy 9.7
810 oncocytoma 9.7
811 retinitis pigmentosa 13 9.7
812 short tarsus with absence of lower eyelashes 9.7
813 aminopterin syndrome sine aminopterin 9.7
814 polyposis syndrome, hereditary mixed, 1 9.7
815 retinitis pigmentosa 18 9.7
816 branchiootic syndrome 1 9.7
817 mental retardation, severe, with spasticity and pigmentary tapetoretinal degeneration 9.7
818 ventricular fibrillation, paroxysmal familial, 1 9.7
819 chudley-mccullough syndrome 9.7
820 nephronophthisis 3 9.7
821 ataxia-telangiectasia-like disorder 1 9.7
822 renal cell carcinoma, papillary, 1 9.7
823 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 9.7
824 temtamy preaxial brachydactyly syndrome 9.7
825 abdominal obesity-metabolic syndrome 1 9.7
826 abdominal obesity-metabolic syndrome quantitative trait locus 2 9.7
827 alveolar soft part sarcoma 9.7
828 parkinson disease 7, autosomal recessive early-onset 9.7
829 maturity-onset diabetes of the young 9.7
830 huntington disease-like 2 9.7
831 inflammatory bowel disease 6 9.7
832 myopathy, distal, with anterior tibial onset 9.7
833 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1 9.7
834 spastic paraplegia 7, autosomal recessive 9.7
835 psoriatic arthritis 9.7
836 familial adenomatous polyposis 2 9.7
837 sick sinus syndrome 1 9.7
838 severe cutaneous adverse reaction 9.7
839 lung cancer susceptibility 1 9.7
840 mutagen sensitivity 9.7
841 skin/hair/eye pigmentation, variation in, 8 9.7
842 kawasaki disease 9.7
843 smoking as a quantitative trait locus 3 9.7
844 colorectal cancer 3 9.7
845 factor xi deficiency 9.7
846 pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis 9.7
847 hemophagocytic lymphohistiocytosis, familial, 5 9.7
848 sex hormone-binding globulin circulating level quantitative trait locus 9.7
849 cholangitis, primary sclerosing 9.7
850 beta-thalassemia 9.7
851 alpha-2-macroglobulin deficiency 9.7
852 breast-ovarian cancer, familial 4 9.7
853 colorectal cancer, hereditary nonpolyposis, type 4 9.7
854 diarrhea 6 9.7
855 leptin deficiency or dysfunction 9.7
856 schuurs-hoeijmakers syndrome 9.7
857 heart and brain malformation syndrome 9.7
858 mulchandani-bhoj-conlin syndrome 9.7
859 drug metabolism, altered, cyp2c8-related 9.7
860 t-cell lymphoma, subcutaneous panniculitis-like 9.7
861 neurodevelopmental, jaw, eye, and digital syndrome 9.7
862 spermatogenic failure 50 9.7
863 hypertrophic scars 9.7
864 chronic ulcer of skin 9.7
865 chronic diarrhea due to guanylate cyclase 2c overactivity 9.7
866 tendinitis 9.7
867 pulmonary hypertension 9.7
868 cutaneous lupus erythematosus 9.7
869 erythema multiforme 9.7
870 congenital hypothyroidism 9.7
871 arrhythmogenic right ventricular cardiomyopathy 9.7
872 brugada syndrome 9.7
873 mantle cell lymphoma 9.7
874 lymphoplasmacytic lymphoma 9.7
875 peripheral t-cell lymphoma 9.7
876 metabolic acidosis 9.7
877 paraganglioma 9.7
878 persistent mullerian duct syndrome 9.7
879 peripheral artery disease 9.7
880 salivary gland carcinoma 9.7
881 tonsil squamous cell carcinoma 9.7
882 gastrointestinal carcinoma 9.7
883 uterine corpus endometrial carcinoma 9.7
884 autosomal recessive cerebellar ataxia 9.7
885 aphasia 9.7
886 cutaneous t cell lymphoma 9.7
887 nonbacterial thrombotic endocarditis 9.7
888 progesterone-receptor negative breast cancer 9.7
889 brain meningioma 9.7
890 connective tissue benign neoplasm 9.7
891 anosognosia 9.7
892 ischemic colitis 9.7
893 clostridium difficile colitis 9.7
894 crohn's colitis 9.7
895 atrial fibrillation 9.7
896 stuttering 9.7
897 lung abscess 9.7
898 umbilical hernia 9.7
899 obstructive nephropathy 9.7
900 physical disorder 9.7
901 intestinal pseudo-obstruction 9.7
902 bladder exstrophy-epispadias-cloacal exstrophy complex 9.7
903 bladder exstrophy 9.7
904 mucinous lung adenocarcinoma 9.7
905 igg4-related disease 9.7
906 desmoid tumor 9.7
907 myxofibrosarcoma 9.7
908 tongue carcinoma 9.7
909 erythema nodosum 9.7
910 diffuse gastric cancer 9.7
911 acute erythroid leukemia 9.7
912 human cytomegalovirus infection 9.7
913 pemphigus foliaceus 9.7
914 paraneoplastic pemphigus 9.7
915 parkinsonism 9.7
916 spinocerebellar ataxia type 1 with axonal neuropathy 9.7
917 castleman disease 9.7
918 distal muscular dystrophy with anterior tibial onset 9.7
919 li-fraumeni syndrome 1 9.7
920 sensorineural hearing loss 9.7
921 pleomorphic lipoma 9.7
922 cholelithiasis 9.7
923 borderline leprosy 9.7
924 prostate lymphoma 9.7
925 viral meningitis 9.7
926 chronic leukemia 9.7
927 prolymphocytic leukemia 9.7
928 microinvasive gastric cancer 9.7
929 cardia cancer 9.7
930 lactose intolerance 9.7
931 protein-losing enteropathy 9.7
932 microphthalmia 9.7
933 duodenum adenocarcinoma 9.7
934 abducens nerve disease 9.7
935 lepromatous leprosy 9.7
936 discitis 9.7
937 q fever 9.7
938 henoch-schoenlein purpura 9.7
939 prostatic cyst 9.7
940 human papillomavirus infectious disease 9.7
941 hypoparathyroidism 9.7
942 spondyloarthropathy 9.7
943 vitamin k deficiency bleeding 9.7
944 gingival recession 9.7
945 bladder calculus 9.7
946 corneal neovascularization 9.7
947 epidural abscess 9.7
948 pulmonary edema 9.7
949 cardiac tamponade 9.7
950 autonomic neuropathy 9.7
951 nephrosclerosis 9.7
952 myopia 9.7
953 cortical blindness 9.7
954 esophagitis 9.7
955 cryptococcosis 9.7
956 chagas disease 9.7
957 lymphocytic choriomeningitis 9.7
958 dengue disease 9.7
959 plica syndrome 9.7
960 atypical depressive disorder 9.7
961 retroperitoneal lymphoma 9.7
962 prostatocystitis 9.7
963 graves' disease 9.7
964 bell's palsy 9.7
965 acute kidney tubular necrosis 9.7
966 paracoccidioidomycosis 9.7
967 acoustic neuroma 9.7
968 hereditary hemorrhagic telangiectasia 9.7
969 enterocele 9.7
970 quadriplegia 9.7
971 guillain-barre syndrome 9.7
972 rectal disease 9.7
973 hereditary spherocytosis 9.7
974 carotid stenosis 9.7
975 branch retinal artery occlusion 9.7
976 central retinal artery occlusion 9.7
977 focal segmental glomerulosclerosis 9.7
978 klebsiella pneumonia 9.7
979 diabetic cataract 9.7
980 color blindness 9.7
981 coccidioidomycosis 9.7
982 scleritis 9.7
983 extrahepatic cholestasis 9.7
984 prostate calculus 9.7
985 acquired color blindness 9.7
986 calcific tendinitis 9.7
987 adult dermatomyositis 9.7
988 autosomal dominant cerebellar ataxia 9.7
989 seminal vesicle adenocarcinoma 9.7
990 reproductive system disease 9.7
991 panniculitis 9.7
992 angioedema 9.7
993 benign breast phyllodes tumor 9.7
994 vascular cancer 9.7
995 pericarditis 9.7
996 peritoneal mesothelioma 9.7
997 urinary system disease 9.7
998 neuritis 9.7
999 hepatitis c 9.7
1000 viral hepatitis 9.7
1001 cholecystitis 9.7
1002 neuroma 9.7
1003 autoimmune hepatitis 9.7
1004 dental caries 9.7
1005 vaginitis 9.7
1006 keratopathy 9.7
1007 atrophy of prostate 9.7
1008 nocardiosis 9.7
1009 neonatal jaundice 9.7
1010 granular cell tumor 9.7
1011 psychotic disorder 9.7
1012 motor peripheral neuropathy 9.7
1013 testicular disease 9.7
1014 alcoholic psychosis 9.7
1015 hematologic cancer 9.7
1016 agammaglobulinemia 9.7
1017 chondroma 9.7
1018 cystadenoma 9.7
1019 synovitis 9.7
1020 dyskeratosis congenita 9.7
1021 long qt syndrome 9.7
1022 melancholia 9.7
1023 endometrial adenocarcinoma 9.7
1024 cervix carcinoma 9.7
1025 cryoglobulinemia 9.7
1026 membranoproliferative glomerulonephritis 9.7
1027 cockayne syndrome 9.7
1028 cystic kidney disease 9.7
1029 germ cell cancer 9.7
1030 breast ductal carcinoma 9.7
1031 acinar cell carcinoma 9.7
1032 cystadenocarcinoma 9.7
1033 papillary adenocarcinoma 9.7
1034 gallbladder cancer 9.7
1035 skin squamous cell carcinoma 9.7
1036 inverted papilloma 9.7
1037 oligodendroglioma 9.7
1038 spinal cord disease 9.7
1039 myelitis 9.7
1040 complex regional pain syndrome 9.7
1041 central nervous system lymphoma 9.7
1042 thymic carcinoma 9.7
1043 perivascular tumor 9.7
1044 mesenchymal cell neoplasm 9.7
1045 histiocytosis 9.7
1046 plague 9.7
1047 pancreatic ductal carcinoma 9.7
1048 kallmann syndrome 9.7
1049 bladder disease 9.7
1050 intermittent claudication 9.7
1051 lung benign neoplasm 9.7
1052 thrombophlebitis 9.7
1053 merkel cell carcinoma 9.7
1054 thyroid gland medullary carcinoma 9.7
1055 linitis plastica 9.7
1056 trophoblastic neoplasm 9.7
1057 orbital cancer 9.7
1058 systemic scleroderma 9.7
1059 articulation disorder 9.7
1060 hypertrichosis 9.7
1061 pyoderma 9.7
1062 radiculopathy 9.7
1063 myofibroma 9.7
1064 granulomatous dermatitis 9.7
1065 fibrous histiocytoma 9.7
1066 cutaneous fibrous histiocytoma 9.7
1067 skull base meningioma 9.7
1068 chromophobe renal cell carcinoma 9.7
1069 large cell carcinoma 9.7
1070 benign meningioma 9.7
1071 bile duct cancer 9.7
1072 uremia 9.7
1073 movement disease 9.7
1074 bronchiolo-alveolar adenocarcinoma 9.7
1075 adenocarcinoma in situ 9.7
1076 elephantiasis 9.7
1077 sleep disorder 9.7
1078 functioning pituitary adenoma 9.7
1079 testicular germ cell cancer 9.7
1080 mediastinal cancer 9.7
1081 acute pyelonephritis 9.7
1082 t-cell acute lymphoblastic leukemia 9.7
1083 eye disease 9.7
1084 lymphoepithelioma-like carcinoma 9.7
1085 comedo carcinoma 9.7
1086 seminal vesicle cystadenoma 9.7
1087 malignant peripheral nerve sheath tumor 9.7
1088 follicular adenoma 9.7
1089 acquired immunodeficiency syndrome 9.7
1090 invasive bladder transitional cell carcinoma 9.7
1091 plasma cell neoplasm 9.7
1092 inherited metabolic disorder 9.7
1093 adrenal adenoma 9.7
1094 diffuse idiopathic skeletal hyperostosis 9.7
1095 bone lymphoma 9.7
1096 lung lymphoma 9.7
1097 prostate small cell carcinoma 9.7
1098 t-cell lymphoblastic leukemia/lymphoma 9.7
1099 thyroiditis 9.7
1100 melanomatosis 9.7
1101 meningothelial meningioma 9.7
1102 axonal neuropathy 9.7
1103 pseudosarcomatous fibromatosis 9.7
1104 nephrogenic adenoma 9.7
1105 anthrax disease 9.7
1106 monoclonal gammopathy of uncertain significance 9.7
1107 parathyroid adenoma 9.7
1108 septic arthritis 9.7
1109 myocarditis 9.7
1110 intestinal obstruction 9.7
1111 localized scleroderma 9.7
1112 retinal artery occlusion 9.7
1113 hypopharynx cancer 9.7
1114 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.7
1115 pyoderma gangrenosum 9.7
1116 oropharynx cancer 9.7
1117 vascular dementia 9.7
1118 atrophic gastritis 9.7
1119 evans' syndrome 9.7
1120 narcolepsy 9.7
1121 parotid gland cancer 9.7
1122 macroglobulinemia 9.7
1123 peliosis hepatis 9.7
1124 gas gangrene 9.7
1125 submandibular gland cancer 9.7
1126 cleft lip 9.7
1127 mechanical strabismus 9.7
1128 lymphangitis 9.7
1129 urethral diverticulum 9.7
1130 diabetes insipidus 9.7
1131 pathologic nystagmus 9.7
1132 noma 9.7
1133 yellow fever 9.7
1134 tenosynovitis 9.7
1135 irritable bowel syndrome 9.7
1136 hypersensitivity vasculitis 9.7
1137 alopecia areata 9.7
1138 muscular dystrophy 9.7
1139 hypervitaminosis d 9.7
1140 drug dependence 9.7
1141 hypoalphalipoproteinemia 9.7
1142 myotonic dystrophy 9.7
1143 mutyh polyposis 9.7
1144 multiple epiphyseal dysplasia, recessive 9.7
1145 sickle cell disease 9.7
1146 amaurosis fugax 9.7
1147 attenuated familial adenomatous polyposis 9.7
1148 biliary tract cancer 9.7
1149 bone marrow necrosis 9.7
1150 chromophil renal cell carcinoma 9.7
1151 chromosome 9 inversion 9.7
1152 chronic thromboembolic pulmonary hypertension 9.7
1153 cryofibrinogenemia 9.7
1154 dendritic cell tumor 9.7
1155 enchondroma 9.7
1156 familial colorectal cancer 9.7
1157 fetal thalidomide syndrome 9.7
1158 grover's disease 9.7
1159 hansen's disease 9.7
1160 homologous wasting disease 9.7
1161 horseshoe kidney 9.7
1162 human t-cell leukemia virus type 1 9.7
1163 hypertrichosis lanuginosa, acquired 9.7
1164 leukemia, t-cell, chronic 9.7
1165 myalgic encephalomyelitis/chronic fatigue syndrome 9.7
1166 mycetoma 9.7
1167 myh-associated polyposis 9.7
1168 opsoclonus-myoclonus syndrome 9.7
1169 ovarian epithelial cancer 9.7
1170 paraneoplastic cerebellar degeneration 9.7
1171 paraneoplastic neurologic disorders 9.7
1172 phocomelia 9.7
1173 post-transplant lymphoproliferative disease 9.7
1174 primary central nervous system lymphoma 9.7
1175 pseudo-turner syndrome 9.7
1176 pure autonomic failure 9.7
1177 ring chromosome 17 9.7
1178 split hand/foot malformation x-linked 9.7
1179 stevens-johnson syndrome/toxic epidermal necrolysis 9.7
1180 superficial spreading melanoma 9.7
1181 t-cell prolymphocytic leukemia 9.7
1182 thalassemia 9.7
1183 trisomy 17 mosaicism 9.7
1184 unicentric castleman disease 9.7
1185 warthin tumor 9.7
1186 pacs1 syndrome 9.7
1187 central precocious puberty 9.7
1188 color vision deficiency 9.7
1189 cavernous malformation 9.7
1190 hypotonia 9.7
1191 posttransplant acute limbic encephalitis 9.7
1192 subacute cutaneous lupus erythematosus 9.7
1193 cleft lip/palate 9.7
1194 systemic autoimmune disease 9.7
1195 low-flow priapism 9.7
1196 specific language disorder 9.7
1197 pouchitis 9.7
1198 virus-associated trichodysplasia spinulosa 9.7
1199 primary bone lymphoma 9.7
1200 silent pituitary adenoma 9.7
1201 pre-descemet corneal dystrophy 9.7
1202 disorders of vitamin d metabolism 9.7
1203 traumatic avascular necrosis 9.7
1204 hereditary gastric cancer 9.7
1205 erythema multiforme major 9.7
1206 cebpe-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome 9.7
1207 non-functioning pituitary adenoma 9.7
1208 premature aging 9.7
1209 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.7
1210 large granular lymphocyte leukemia 9.7
1211 cardiogenic shock 9.7
1212 glomerular disease 9.7
1213 intraductal tubulopapillary neoplasm of pancreas 9.7

Graphical network of the top 20 diseases related to Prostate Cancer, Hereditary, 6:



Diseases related to Prostate Cancer, Hereditary, 6

Symptoms & Phenotypes for Prostate Cancer, Hereditary, 6

Clinical features from OMIM®:

609558 (Updated 20-May-2021)

Drugs & Therapeutics for Prostate Cancer, Hereditary, 6

Drugs for Prostate Cancer, Hereditary, 6 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 760, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ofloxacin Approved Phase 4 82419-36-1 4583
2
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
3
Udenafil Approved, Investigational Phase 4 268203-93-6 6918523
4
Dutasteride Approved, Investigational Phase 4 164656-23-9 152945 6918296
5
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
6
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
7
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570
8
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
9
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
10
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
11
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
12
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
13
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
14
Ondansetron Approved Phase 4 99614-02-5 4595
15
Granisetron Approved, Investigational Phase 4 109889-09-0 3510
16
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
17
Desflurane Approved Phase 4 57041-67-5 42113
18
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
19
Mepivacaine Approved, Vet_approved Phase 4 96-88-8 4062
20
Denosumab Approved Phase 4 615258-40-7
21
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
22
Pamidronate Approved Phase 4 40391-99-9 4674
23
Abarelix Approved, Investigational, Withdrawn Phase 4 183552-38-7 16131215
24
Heparin Approved, Investigational Phase 4 9005-49-6 772 9812414
25
Dihydrotestosterone Illicit, Investigational Phase 4 521-18-6 10635
26 Phosphodiesterase 5 Inhibitors Phase 4
27 Analgesics Phase 4
28 5-alpha Reductase Inhibitors Phase 4
29 Neurotransmitter Agents Phase 4
30 Psychotropic Drugs Phase 4
31 Anti-Anxiety Agents Phase 4
32 Excitatory Amino Acid Antagonists Phase 4
33 Anesthetics, Local Phase 4
34 Plasma Substitutes Phase 4
35 Blood Substitutes Phase 4
36 Angelica Phase 4
37 Dong Quai Phase 4
38 Analgesics, Opioid Phase 4
39 Hypnotics and Sedatives Phase 4
40 Anesthetics, Intravenous Phase 4
41 GABA Modulators Phase 4
42 Dopamine Antagonists Phase 4
43 Antipsychotic Agents Phase 4
44 Adrenergic alpha-Agonists Phase 4
45 Ophthalmic Solutions Phase 4
46 Adrenergic Agonists Phase 4
47 Brimonidine Tartrate Phase 4 70359-46-5
48 Anesthetics, Inhalation Phase 4
49 Hydroxyethyl Starch Derivatives Phase 4
50 Anesthetics, Dissociative Phase 4
51
protease inhibitors Phase 4
52 HIV Protease Inhibitors Phase 4
53 Contraceptive Agents Phase 4
54 Triptorelin Pamoate Phase 4
55 Anesthetics Phase 4
56 Fibrinolytic Agents Phase 4
57 calcium heparin Phase 4
58 Anesthetics, General Phase 4
59
Hyaluronic acid Approved, Vet_approved Phase 2, Phase 3 9004-61-9 53477741
60
Nitroglycerin Approved, Investigational Phase 3 55-63-0 4510
61
Melphalan Approved Phase 2, Phase 3 148-82-3 4053 460612
62
Zoledronic Acid Approved Phase 3 118072-93-8 68740
63
Glycolic acid Approved, Investigational Phase 3 79-14-1 757
64
Lycopene Approved, Investigational Phase 2, Phase 3 502-65-8 446925
65 Tomato Approved Phase 2, Phase 3
66
Bevacizumab Approved, Investigational Phase 3 216974-75-3
67
Dasatinib Approved, Investigational Phase 3 302962-49-8 3062316
68
Cyproterone Acetate Approved, Investigational Phase 3 427-51-0
69
Pancrelipase Approved, Investigational Phase 3 53608-75-6
70
Nadroparin Approved, Investigational Phase 3
71
Dalteparin Approved Phase 3 9005-49-6
72
Tinzaparin Approved Phase 3 9041-08-1, 9005-49-6 25244225
73
Etoposide Approved Phase 3 33419-42-0 36462
74
Diethylstilbestrol Approved, Investigational Phase 3 56-53-1 3054 448537
75
Sufentanil Approved, Investigational Phase 3 56030-54-7 41693
76
Tamoxifen Approved Phase 3 10540-29-1 2733526
77
Calcium carbonate Approved, Investigational Phase 3 471-34-1
78
Rofecoxib Approved, Investigational, Withdrawn Phase 3 162011-90-7 5090
79
Leflunomide Approved, Investigational Phase 2, Phase 3 75706-12-6 3899
80
Modafinil Approved, Investigational Phase 3 68693-11-8 4236